Evidence map›Paper›PMID 31008735›Full record

ArticleThe American journal of gastroenterology2019

Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter Consortium.

Robert D Pesek, Craig C Reed, Amanda B Muir, Patricia C Fulkerson, Calies Menard-Katcher, Gary W Falk, Jonathan Kuhl, Ellen K Martin, Adam Z Magier, Faria Ahmed and 13 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in The American journal of gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 1 pooled it
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 1 synthesis or guideline pooled it, 148 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Eosinophilic gastrointestinal diseases.Nature reviews. Disease primers · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Eosinophilic gastroduodenitis: a pediatric perspective.Italian journal of pediatrics · 2025
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Segmental overlap is common in eosinophilic gastrointestinal diseases and impacts clinical presentation and treatment.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2025
    Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 10 institutions in 1 country.

Robert D PesekDivision of Allergy/Immunology, Department of Pediatrics, University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock, Arkansas, USA.
Craig C ReedCenter for Esophageal Diseases and Swallowing and Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Amanda B MuirDivision of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Patricia C FulkersonDivision of Allergy/Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Calies Menard-KatcherDivision of Gastroenterology, Department of Pediatrics, Children's Hospital Colorado, Denver, Colorado, USA.
Gary W FalkDivision of Gastroenterology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Jonathan KuhlDivision of Allergy/Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Ellen K MartinDivision of Allergy/Immunology, Department of Pediatrics, University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock, Arkansas, USA.
Adam Z MagierDivision of Allergy/Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Faria AhmedDivision of Gastroenterology, Department of Pediatrics, Children's Hospital Colorado, Denver, Colorado, USA.
Maureen DemarshallDivision of Gastroenterology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Ankur GuptaDivision of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Jonathan GrossDivision of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Tokunbo AshorobiDivision of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Christina L CarpenterRare Disease Clinical Research Network Data Coordinating Center, Health Informatics Institute, University of South Florida, Tampa, Florida, USA.
Jeffrey P KrischerRare Disease Clinical Research Network Data Coordinating Center, Health Informatics Institute, University of South Florida, Tampa, Florida, USA.
Nirmala GonsalvesDivision of Gastroenterology and Hepatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Jonathan M SpergelDivision of Allergy and Immunology, The Children's Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine of University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Sandeep K GuptaDivision of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital of Illinois and the University of Illinois College of Medicine, Peoria, Illinois, USA.
Glenn T FurutaDivision of Gastroenterology, Department of Pediatrics, Children's Hospital Colorado, Denver, Colorado, USA.
Marc E RothenbergDivision of Allergy/Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Evan S DellonCenter for Esophageal Diseases and Swallowing and Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)
Children's Hospital of Philadelphia · USUniversity of Cincinnati · USUniversity of Colorado Denver · USUniversity of Pennsylvania · USArkansas Children's Hospital · USUniversity of North Carolina at Chapel Hill · USCincinnati Children's Hospital Medical Center · USNorthwestern University · USResearch Network (United States) · USUniversity of South Florida · US

Funding

Stem Cell/Organoid and Genome Editing CoreP30DK078392 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Theresa Alenghat · 2007 to 2026
$24.4M
TRAINING (CAREER DEVELOPMENT) COMPONENTU54AI117804 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI GLENN T FURUTA, Marc E. Rothenberg · 2014 to 2026
$18.5M
DIGESTIVE DISEASES EPIDEMIOLOGY TRAINING PROGRAMT32DK007634 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROBERT S. SANDLER · 1990 to 2026
$7.4M
Structural and molecular markers for detection and monitoring of pediatric fibrostenotic Eosinophilic EsophagitisK23DK109263 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI MENARD-KATCHER, CALIES D · 2016 to 2021
$1.0M
NIAID NIH HHS U54 AI117804NIDDK NIH HHS K23 DK109263NIDDK NIH HHS P30 DK078392NIDDK NIH HHS T32 DK007634
6 · The paper itself

Abstract

objectivesThe literature related to eosinophilic gastritis (EG), gastroenteritis (EGE), and colitis (EC) is limited. We aimed to characterize rates of diagnosis, clinical features, and initial treatments for patients with EG, EGE, and EC.

methodsIn this retrospective study, data were collected from 6 centers in the Consortium of Eosinophilic Gastrointestinal Researchers from 2005 to 2016. We analyzed demographics, time trends in diagnosis, medical history, presenting symptoms, disease overlap, and initial treatment patterns/responses.

resultsOf 373 subjects (317 children and 56 adults), 38% had EG, 33% EGE, and 29% EC. Rates of diagnosis of all diseases increased over time. There was no male predominance, and the majority of subjects had atopy. Presenting symptoms were similar between diseases with nausea/vomiting and abdominal pain, the most common. One hundred fifty-four subjects (41%) had eosinophilic inflammation outside of their primary disease location with the esophagus the second most common gastrointestinal (GI) segment involved. Multisite inflammation was more common in children than in adults (68% vs 37%; P < 0.001). Initial treatment patterns varied highly between centers. One hundred-nine subjects (29%) had follow-up within 6 months, and the majority had clinical, endoscopic, and histologic improvements.

conclusionsIn this cohort, EG, EGE, and EC were diagnosed more frequently over time, and inflammation of GI segments outside the primary disease site co-occurrence of atopy was common with a lack of male predominance. Symptoms were similar between diseases, and initial treatment strategies were highly variable. Future investigation should assess the cause of the increased prevalence of eosinophilic GI disorders and prospectively assess outcomes to establish treatment algorithms.

Indexed as

AdolescentAdultAnti-Inflammatory AgentsChildChild, PreschoolColitisComorbidityEnteritisEosinophiliaEosinophilsFemaleFollow-Up StudiesForecastingGastritisGastroenteritisGastrointestinal AgentsAnti-Inflammatory AgentsGastrointestinal Agents

Identifiers

PMID31008735
PMCPMC6554065
OpenAlexW2950049244

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.